Log In
BCIQ
Print this Print this
 

acumapimod (BCT-197)

  Manage Alerts
Collapse Summary General Information
Company Mereo BioPharma Group Ltd.
DescriptionOrally active p38 mitogen-activated protein kinase (p38 MAPK;MAPK14) kinase inhibitor
Molecular Target p38 mitogen-activated protein kinase (p38 MAPK) (MAPK14)
Mechanism of ActionMAP kinase (p38) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationChronic obstructive pulmonary disease (COPD)
Indication DetailsTreat acute exacerbations of chronic obstructive pulmonary disease (COPD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/29/2015

Undisclosed

0

Undisclosed

Get a free BioCentury trial today